NCT06546215View on ClinicalTrials.gov

Bioequivalence Study of Digoxin Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 5, 2020

Primary Completion Date

January 23, 2021

Study Completion Date

January 23, 2021

Conditions
Heart Failure
Interventions
DRUG

Digoxin

Administer a single-dose (0.25mg) of either the reference or the test formulation of digoxin tablets.

Trial Locations (1)

410008

Xiangya Hospital Central South University, Changsha

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER

NCT06546215 - Bioequivalence Study of Digoxin Tablet in Healthy Subjects | Biotech Hunter | Biotech Hunter